Petros Grivas

Academic History

Petros Grivas, MD, PhD, is a Professor in the Clinical Research Division and Clinical Director of the Genitourinary Cancers Program at Fred Hutchinson Cancer Center, Seattle, WA, and a Professor in the Division of Hematology and Oncology at the University of Washington, Seattle, WA. Prof. Grivas earned his medical degree and PhD in Medical Oncology from the University of Patras, Patras, Greece, followed by residency at Drexel University College of Medicine/Hahnemann University Hospital, Philadelphia, PA, and a fellowship in Hematology/Oncology at the University of Michigan, Ann Arbor, MI. He is board-certified in Internal Medicine and Medical Oncology.

Speaking on clinical trial and immunotherapy in genitourinary Cancers

Prof. Grivas specializes in the development and testing of novel therapies for genitourinary cancers, including bladder, prostate, and testicular cancers. His work focuses on immunotherapy, checkpoint inhibitors, and targeted agents. As principal investigator of numerous clinical trials, he has played a pivotal role in research that led to FDA approval for new drugs in bladder and urothelial cancers.